Functional studies for the TRAF6 mutation associated with hypohidrotic ectodermal dysplasia

British Journal of Dermatology

Volumn 168, Issue 3, 2013, Pages 629-633

  Fujikawa, H ^a   Farooq, M ^a   Fujimoto, A ^a   Ito, M ^a   Shimomura, Y ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EDAR ASSOCIATED DEATH DOMAIN PROTEIN; EDAR PROTEIN, HUMAN; EDAR RECEPTOR; EDARADD PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TAB1 PROTEIN, HUMAN; TAB2 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ARTICLE; DRUG INTERACTION; GENETICS; HUMAN; HYPOHIDROTIC ECTODERMAL DYSPLASIA; IMMUNOPRECIPITATION; METABOLISM; MUTATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; DRUG INTERACTIONS; ECTODERMAL DYSPLASIA, HYPOHIDROTIC, AUTOSOMAL RECESSIVE; EDAR RECEPTOR; EDAR-ASSOCIATED DEATH DOMAIN PROTEIN; HUMANS; IMMUNOPRECIPITATION; MUTATION; NF-KAPPA B; TNF RECEPTOR-ASSOCIATED FACTOR 6;

EID: 84882266710     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12018     Document Type: Article

References (15)

1. Kere J, Srivastava AK, Montonen O et al. X-linked anhidrotic (hypohidrotic) ectodermal dysplasia is caused by mutation in a novel transmembrane protein. Nat Genet 1996;13:409-16.
2. Monreal AW, Ferguson BM, Headon DJ et al. Mutations in the human homologue of mouse dl cause autosomal recessive and dominant hypohidrotic ectodermal dysplasia. Nat Genet 1999;22:366-9.
3. Headon DJ, Emmal SA, Ferguson BM et al. Gene defect in ectodermal dysplasia implicates a death domain adapter in development. Nature 2001;414:913-16.
4. Bal E, Baala L, Cluzeau C et al. Autosomal dominant anhidrotic ectodermal dysplasias at the EDARADD locus. Hum Mutat 2007;28:703-9.
5. Yan M, Wang LC, Hymowitz SG et al. Two-amino acid molecular switch in an epithelial morphogen that regulates binding to two distinct receptors. Science 2000;290:523-7.
6. Morlon A, Munnich A, Smahi A. TAB 2, TRAF6 and TAK1 are involved in NF-kappaB activation induced by the TNF-receptor, EDAR and its adaptator EDARADD. Hum Mol Genet 2005;14:3751-7.
7. Naito A, Yoshida H, Nishioka E et al. TRAF6-deficient mice display hypohidrotic ectodermal dysplasia. Proc Natl Acad Sci USA 2002;99:8766-71.
8. Wisniewski SA, Trzeciak WH. A rare heterozygous TRAF6 variant is associated with hypohidrotic ectodermal dysplasia. Br J Dermatol 2012;166:1353-6.
9. Niwa H, Yamamura K, Miyazaki J. Efficient selection for highexpression transfectants with a novel eukaryotic vector. Gene 1991;108:193-9.
10. Shimomura Y, Sato N, Miyashita A et al. A rare case of hypohidrotic ectodermal dysplasia caused by compound heterozygous mutations in the EDAR gene. J Invest Dermatol 2004;123:649-55.
11. Shimomura Y, Agalliu D, Vonica A et al. APCDD1 is a novel Wnt inhibitor mutated in hereditary hypotrichosis simplex. Nature 2010;464:1043-7.
12. Fujikawa H, Fujimoto A, Farooq M et al. Characterization of human keratin-associated protein 2 (KRTAP2) gene family. J Invest Dermatol 2012;132:1806-13.
13. Ye H, Arron JR, Lamothe B et al. Distinct molecular mechanism for initiating TRAF6 signalling. Nature 2002;418:443-7.
14. Megas C, Hatzivassiliou EG, Yin Q et al. Mutational analysis of TRAF6 reveals a conserved functional role of the RING dimerization interface and a potentially necessary but insufficient role of RING-dependent TRAF6 polyubiquitination towards NF-jB activation. Cell Signal 2011;23:772-7.
15. Yin Q, Lin SC, Lamothe B et al. E2 interaction and dimerization in the crystal structure of TRAF6. Nat Struct Mol Biol 2009;16:658-66.